TC Biopharm (Holdings) Plc

NASDAQ (USD): TC Biopharm (Holdings) Plc (TCBP)

Last Price

0.529

Today's Change

-0.055 (9.41%)

Day's Change

0.49 - 0.60

Trading Volume

327,667

Profile
TCBP

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Bryan Leland Kobel Mr. Bryan Leland Kobel

Full Time Employees:  41 41

IPO Date:  2022-02-11 2022-02-11

CIK:  0001872812 0001872812

ISIN:  US87807D4007 US87807D4007

CUSIP:  87807D103 87807D103

Beta:  0.25 0.25

Last Dividend:  0.00 0.00

Dcf Diff:  3.88 3.88

Dcf:  2.82 2.82

Description

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Address

Maxim 1,
Motherwell, ML1 4WR, GB

44 14 1433 7557

http://www.tcbiopharm.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment